The Immune Response of Carbon-based Nano Light Vaccines to SARS-CoV-2
Diagnostic and Treatment Advances in COVID-19 and SARS-CoV-2,
9 February 2023
,
Page 147-155
https://doi.org/10.9734/bpi/mono/978-81-19039-63-0/CH10
Abstract
Elucidating the panoramic mechanism of coronavirus-host immune interaction is a strategy for disease surveillance, diagnosis, treatment, prevention, and immunity assessment of COVID-19. A robust carbon-based nano light vaccine technology system contributes to achieving the core scientific issues of this strategy. In this review, we state the latest prevention and control strategy of carbon-based nano light vaccine, and their broad-spectrum resistance to high transmissible and pathogenic variants. Furthermore, we cover the immune response to SARS-CoV-2 under carbon-based nano light vaccine intervention, and finally evaluate the efficacy of carbon-based nano light vaccines and their interactive mechanisms. The search for highly efficient, conserved T cell epitopes provide a basis for development of a new generation of T cell vaccine.
- SARS-CoV-2
- vaccines
- carbon nanotube
- immune response